Fuad El-Hibri, Chairman at Emergent BioSolutions Inc. (EBS), sold 109,156 shares at $61.83 ($6.7M) on 2020-04-09, disclosed to the SEC on 2020-04-10.
Seasonal sale ($6.7M) by Chairman — this insider has traded EBS in April in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $60.75 | 13,000 | $790K | 11.8% |
| 2 | $61.34 | 24,362 | $1.5M | 22.3% |
| 3 | $61.34 | 24,362 | $1.5M | 22.3% |
| 4 | $61.83 | 23,716 | $1.5M | 21.8% |
| 5 | $61.83 | 23,716 | $1.5M | 21.8% |
| Total | $61.48 avg | 109,156 |
| $6.7M |
| 100% |
| Filing → |
| EBS | SELL | 2020-09-25 | $3.8M | — | Filing → |
| EBS | SELL | 2020-09-18 | $6.1M | — | Filing → |
| EBS | SELL | 2020-09-11 | $4.1M | — | Filing → |